Dr. Paul Kruszka

Genentech Professor of Pediatrics • University of Virginia School of Medicine

arrow_back Back to Speakers
Dr. Paul Kruszka
International Faculty
USA

Dr. Paul Kruszka, MD, MPH, FACMG

Genentech Professor of Pediatrics
Director, Division of Pediatric Genetics
Department of Pediatrics, University of Virginia School of Medicine

Email: pk3e@uvahealth.org | Cell: 434-320-5915

Education and Training

  • 07/2011-07/2014 | Clinical Genetics Residency, The National Human Genome Research Institute, NIH, Bethesda MD
  • 01/2009-07/2011 | Master of Public Health, University of Massachusetts, Amherst MA
  • 07/1998-06/2001 | Family Medicine Residency, University of Virginia, Charlottesville VA
  • 08/1994-05/1998 | Doctor of Medicine, University of Michigan, Ann Arbor MI
  • 07/1985-05/1989 | Bachelor of Science, U.S. Naval Academy, Annapolis MD

Professional Experience

  • 12/2025-present | Genentech Professor of Pediatrics (Endowed Professorship)
  • 04/2025-present | Director, Division of Pediatric Genetics, Professor of Pediatrics, University of Virginia
  • 04/2021-04/2025 | Chief Medical Officer at GeneDx.
  • 03/2022-present | Clinical geneticist, Rare Disease Institute at Children’s National Medical Center (part-time)
  • 07/2014-03/2021 | Associate Research Physician. National Human Genome Research Institute (NHGRI).
  • 09/2007-03/2021 | Commission Corps officer in the U.S. Public Health Service (retired Captain)
  • 09/2007-07/2011 | Senior Medical Officer -Primary Care, U.S. Public Health Service/U.S. Coast Guard

Honors and Awards

  • 2026 | Virginia’s Top Doctors 2026: Pediatric Genetics
  • 2025 | Rare Disease Ambassador of the Year, GeneDx
  • 2019 | GREAT Award for identifying novel causes underlying holoprosencephaly
  • 2018 | John Opitz Award
  • 2017 | GREAT Award for co-creator of Atlas of Human Malformations in Diverse Populations
  • 2013 | U.S. Public Health Service Physician Researcher of the Year

Professional Memberships

  • 2025-present | Governor of Virginia’s Committee on Rare Disease
  • 2023 | Turner Syndrome International Guideline Committee
  • 2022–2025 | ACMG NICU Evidence-Based Guideline Chairperson
  • 2021–2025 | ACMG Professional Practice and Guideline Committee Member
  • 2019–present | ClinGen Craniosynostosis Gene Curation Expert Panel (GCEP)